Precipio EBITDA Margin 2012-2025 | PRPO
Current and historical EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) margin for Precipio (PRPO) over the last 10 years. The current EBITDA margin for Precipio as of September 30, 2025 is .
| Precipio EBITDA Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM EBITDA | EBITDA Margin |
| 2025-09-30 | $0.02B | 0 | 0.00% |
| 2025-06-30 | $0.02B | 0 | 0.00% |
| 2025-03-31 | $0.02B | $0.00B | -5.26% |
| 2024-12-31 | $0.02B | $0.00B | -17.65% |
| 2024-09-30 | $0.02B | $0.00B | -18.75% |
| 2024-06-30 | $0.02B | $0.00B | -25.00% |
| 2024-03-31 | $0.02B | $-0.01B | -31.25% |
| 2023-12-31 | $0.02B | $-0.01B | -37.50% |
| 2023-09-30 | $0.01B | $-0.01B | -57.14% |
| 2023-06-30 | $0.01B | $-0.01B | -90.91% |
| 2023-03-31 | $0.01B | $-0.01B | -111.11% |
| 2022-12-31 | $0.01B | $-0.01B | -137.50% |
| 2022-09-30 | $0.01B | $-0.01B | -150.00% |
| 2022-06-30 | $0.01B | $-0.01B | -137.50% |
| 2022-03-31 | $0.01B | $-0.01B | -137.50% |
| 2021-12-31 | $0.01B | $-0.01B | -112.50% |
| 2021-09-30 | $0.01B | $-0.01B | -100.00% |
| 2021-06-30 | $0.01B | $-0.01B | -100.00% |
| 2021-03-31 | $0.01B | $-0.01B | -114.29% |
| 2020-12-31 | $0.01B | $-0.01B | -116.67% |
| 2020-09-30 | $0.01B | $-0.01B | -140.00% |
| 2020-06-30 | $0.00B | $-0.01B | -175.00% |
| 2020-03-31 | $0.00B | $-0.01B | -175.00% |
| 2019-12-31 | $0.00B | $-0.01B | -200.00% |
| 2019-09-30 | $0.00B | $-0.01B | -150.00% |
| 2019-06-30 | $0.00B | $-0.01B | -200.00% |
| 2019-03-31 | $0.00B | $-0.01B | -200.00% |
| 2018-12-31 | $0.00B | $-0.01B | -200.00% |
| 2018-09-30 | $0.00B | $-0.01B | -225.00% |
| 2018-06-30 | $0.00B | $-0.01B | -200.00% |
| 2018-03-31 | $0.00B | $-0.01B | -250.00% |
| 2017-12-31 | $0.00B | $0.00B | -400.00% |
| 2017-09-30 | $0.00B | $0.00B | -200.00% |
| 2017-06-30 | $0.00B | $0.00B | -100.00% |
| 2017-03-31 | $0.00B | 0 | 0.00% |
| 2016-12-31 | $0.00B | $0.00B | -50.00% |
| 2016-09-30 | $0.00B | $0.00B | -400.00% |
| 2016-06-30 | $0.00B | $-0.01B | -600.00% |
| 2016-03-31 | $0.00B | $-0.01B | 0.00% |
| 2015-12-31 | $0.00B | $-0.01B | -800.00% |
| 2015-09-30 | $-0.02B | $-0.01B | 40.00% |
| 2015-06-30 | $-0.01B | $-0.01B | 63.64% |
| 2015-03-31 | $0.00B | $-0.01B | 200.00% |
| 2014-12-31 | $0.00B | $-0.01B | -900.00% |
| 2014-09-30 | $0.02B | $-0.01B | -52.17% |
| 2014-06-30 | $0.03B | $-0.01B | -53.85% |
| 2014-03-31 | $0.03B | $-0.01B | -50.00% |
| 2013-12-31 | $0.03B | $-0.01B | -48.15% |
| 2013-09-30 | $0.03B | $-0.01B | -46.43% |
| 2013-06-30 | $0.03B | $-0.01B | -34.48% |
| 2013-03-31 | $0.03B | $-0.01B | -29.03% |
| 2012-12-31 | $0.03B | $-0.01B | -25.81% |
| 2012-09-30 | $0.03B | $-0.01B | -15.15% |
| 2012-06-30 | $0.03B | $0.00B | -9.09% |
| 2012-03-31 | $0.03B | $0.00B | -9.38% |
| 2011-12-31 | $0.03B | $0.00B | -3.13% |
| 2011-09-30 | $0.03B | $0.00B | -7.14% |
| 2011-06-30 | $0.02B | $0.00B | -12.50% |
| 2011-03-31 | $0.02B | $0.00B | -14.29% |
| 2010-12-31 | $0.02B | $0.00B | -15.79% |
| 2010-09-30 | $0.02B | $0.00B | -4.76% |
| 2010-06-30 | $0.02B | 0 | 0.00% |
| 2010-03-31 | $0.02B | 0 | 0.00% |
| 2009-12-31 | $0.02B | $0.00B | -4.55% |
| 2009-09-30 | $0.02B | $0.00B | -9.52% |
| 2009-06-30 | $0.02B | $0.00B | -9.52% |
| 2009-03-31 | $0.02B | $0.00B | -4.55% |
| 2008-12-31 | $0.02B | 0 | 0.00% |
| 2008-09-30 | $0.02B | 0 | 0.00% |
| 2008-06-30 | $0.02B | $0.00B | -4.17% |
| 2008-03-31 | $0.02B | $0.00B | -4.17% |
| 2007-12-31 | $0.02B | $0.00B | -8.70% |
| 2007-09-30 | $0.02B | $0.00B | -9.09% |
| 2007-06-30 | $0.02B | $0.00B | -9.09% |
| 2007-03-31 | $0.02B | $0.00B | -9.09% |
| 2006-12-31 | $0.02B | $0.00B | -4.35% |
| 2006-09-30 | $0.02B | $0.00B | -4.55% |
| 2006-06-30 | $0.02B | $0.00B | 4.17% |
| 2006-03-31 | $0.03B | $0.00B | 8.00% |
| 2005-12-31 | $0.03B | $0.00B | 11.54% |
| 2005-09-30 | $0.03B | $0.00B | -3.45% |
| 2005-06-30 | $0.03B | $-0.01B | -20.00% |
| 2005-03-31 | $0.03B | $-0.02B | -65.63% |
| 2004-12-31 | $0.03B | $-0.02B | -70.59% |
| 2004-09-30 | $0.04B | $-0.02B | -62.86% |
| 2004-06-30 | $0.04B | $-0.02B | -65.71% |
| 2004-03-31 | $0.03B | $-0.01B | -35.29% |
| 2003-12-31 | $0.04B | $-0.01B | -37.14% |
| 2003-09-30 | $0.04B | $-0.02B | -45.71% |
| 2003-06-30 | $0.04B | $-0.02B | -41.67% |
| 2003-03-31 | $0.04B | $-0.02B | -40.54% |
| 2002-12-31 | $0.04B | $-0.02B | -40.54% |
| 2002-09-30 | $0.04B | $-0.01B | -30.77% |
| 2002-06-30 | $0.04B | $-0.01B | -22.50% |
| 2002-03-31 | $0.04B | $-0.01B | -17.07% |
| 2001-12-31 | $0.04B | $-0.01B | -15.38% |
| 2001-09-30 | $0.04B | $-0.01B | -17.14% |
| 2001-06-30 | $0.03B | $-0.01B | -22.58% |
| 2001-03-31 | $0.03B | $-0.01B | -29.63% |
| 2000-12-31 | $0.03B | $-0.01B | -34.62% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.041B | $0.019B |
| Precipio Inc. has built a platform designed to eradicate the problem of misdiagnosis by harnessing the intellect, expertise and technology developed within academic institutions and delivering quality diagnostic information to physicians and their patients worldwide. Through its collaborations with world-class academic institutions specializing in cancer research, diagnostics and treatment, Precipio offers a new standard of diagnostic accuracy enabling the highest level of patient care. Precipio Inc., formerly known as Transgenomic Inc., is based in Omaha, United States of America. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $28.621B | 33.10 |
| Tempus AI (TEM) | United States | $9.242B | 0.00 |
| IRhythm Holdings (IRTC) | United States | $4.646B | 0.00 |
| Doximity (DOCS) | United States | $4.621B | 20.02 |
| Hims & Hers Health (HIMS) | United States | $3.711B | 30.18 |
| Hinge Health (HNGE) | United States | $3.065B | 0.00 |
| Privia Health (PRVA) | United States | $2.754B | 172.23 |
| 10x Genomics (TXG) | United States | $2.293B | 0.00 |
| Heartflow (HTFL) | United States | $1.759B | 0.00 |
| Inspire Medical Systems (INSP) | United States | $1.736B | 23.16 |
| Omnicell (OMCL) | United States | $1.638B | 45.62 |
| Azenta (AZTA) | United States | $1.318B | 53.00 |
| Enovis (ENOV) | United States | $1.245B | 6.54 |
| Clover Health Investments (CLOV) | United States | $1.044B | 0.00 |
| Schrodinger (SDGR) | United States | $0.840B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.768B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.724B | 0.00 |
| Phreesia (PHR) | United States | $0.720B | 0.00 |
| Talkspace (TALK) | United States | $0.625B | 125.67 |
| Standard BioTools (LAB) | United States | $0.431B | 0.00 |
| Claritev (CTEV) | United States | $0.380B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.338B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.320B | 0.00 |
| Evolent Health (EVH) | United States | $0.311B | 0.00 |
| Senseonics Holdings (SENS) | United States | $0.307B | 0.00 |
| TruBridge (TBRG) | United States | $0.293B | 13.45 |
| Carlsmed (CARL) | United States | $0.291B | 0.00 |
| CapsoVision (CV) | United States | $0.226B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.216B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.161B | 0.00 |
| Insight Molecular Diagnostics (IMDX) | United States | $0.160B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.151B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.130B | 0.00 |
| CareCloud (CCLD) | United States | $0.098B | 5.40 |
| American Well (AMWL) | United States | $0.088B | 0.00 |
| 111 (YI) | China | $0.070B | 0.00 |
| NetraMark Holdings (AINMF) | Canada | $0.064B | 0.00 |
| Outset Medical (OM) | United States | $0.062B | 0.00 |
| Pulmonx (LUNG) | United States | $0.061B | 0.00 |
| HeartBeam (BEAT) | United States | $0.053B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.032B | 0.00 |
| Evaxion - (EVAX) | Denmark | $0.028B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.020B | 0.00 |
| Lunai Bioworks (LNAI) | United States | $0.017B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.015B | 0.00 |
| Movano (MOVE) | United States | $0.013B | 0.00 |
| HeartSciences (HSCS) | United States | $0.010B | 0.00 |
| ITonic Holdings (ITOC) | China | $0.007B | 0.00 |
| Zhongchao (ZCMD) | China | $0.005B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.005B | 0.00 |
| PROFUSA (PFSA) | United States | $0.002B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.002B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.001B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.001B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.001B | 0.00 |